Montefiore Medical Center
Clinical trials sponsored by Montefiore Medical Center, explained in plain language.
-
Can bringing addiction treatment to syringe programs save more lives?
Disease control Not yet recruitingThis study tests whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay on medication for opioid use disorder compared to referring them elsewhere. About 512 adults who use SSPs and have moderate to severe opioid use …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
One shot to stop asthma ER visits? new trial tests simpler fix
Disease control Not yet recruitingThis study tests whether a single injection of dexamethasone works as well as a 5-day course of prednisone pills to prevent asthma patients from returning to the emergency room. About 182 adults with asthma will be randomly assigned to get either the shot or the pills. Researcher…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can cannabis compounds boost opioid addiction treatment?
Disease control Not yet recruitingThis study tests whether adding two FDA-approved cannabinoids—dronabinol (synthetic THC) and epidiolex (CBD)—to standard buprenorphine treatment can help people with opioid use disorder stay in treatment and reduce opioid use. The trial will enroll 40 adults who recently started …
Phase: PHASE3 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New lung cancer trial combines immunotherapy and targeted radiation
Disease control Not yet recruitingThis phase 2 trial tests two different immunotherapy drug combinations (durvalumab with monalizumab or oleclumab) followed by personalized radiation for people with advanced non-small cell lung cancer that has a high PD-L1 score. The goal is to see which combination works better …
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New nausea drug could replace standard ER treatment
Symptom relief Not yet recruitingThis study will compare two nausea medications, fosaprepitant and metoclopramide, in 212 adults who come to the emergency department with nausea or vomiting. The goal is to see which drug provides faster and more lasting relief with fewer side effects. Fosaprepitant is a newer dr…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a smartphone app ease the Gut-Brain struggle for IBD patients?
Symptom relief Not yet recruitingThis study tests a mobile app designed to help Black and Hispanic adults with inflammatory bowel disease (IBD) manage stress and improve their quality of life. The app teaches coping skills, mindfulness, and disease acceptance. Researchers want to see if the app is practical and …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Which IV drug eases concussion symptoms best? new trial aims to find out
Symptom relief Not yet recruitingThis study tests two intravenous medications—metoclopramide and acetaminophen—to see which one better relieves acute concussion symptoms like headache, dizziness, and nausea in emergency room patients. Researchers will enroll 200 adults with mild head injuries and track their sym…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Antibiotics may not be needed for mild diverticulitis, new US trial suggests
Symptom relief Not yet recruitingThis trial tests whether people with mild diverticulitis can be safely treated at home with just pain medicines (ibuprofen and acetaminophen) instead of antibiotics. 556 participants will be randomly assigned to receive either pain medicines alone or pain medicines plus an antibi…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Pill or IV? new study tests which acetaminophen works faster for pelvic pain
Symptom relief Not yet recruitingThis study compares intravenous (IV) acetaminophen to oral acetaminophen for treating acute pelvic pain in the emergency department. About 140 women with pelvic pain and a pain score of 4 or higher will be randomly assigned to receive either IV or oral acetaminophen, plus a dummy…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a smartphone app improve cancer care? new study tests personalized nutrition and activity guidance
Symptom relief Not yet recruitingThis study will test whether a mobile app called RestoreMe can help cancer patients get personalized nutrition and activity advice. Researchers plan to enroll 150 adults who are about to start, are currently receiving, or have completed cancer treatment. Participants will use the…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can reused surgical tools be just as good? new study tests Eco-Friendly wands for tonsil surgery
Knowledge-focused Not yet recruitingThis study will compare new, single-use coblator wands with reprocessed (cleaned and reused) wands in 30 children having tonsil or adenoid surgery. The main goal is to see if surgeons are just as comfortable using the reprocessed wands. The study also looks at technical issues an…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
C-Section bladder flap may be unnecessary, new study suggests
Knowledge-focused Not yet recruitingThis study looks at whether making a bladder flap during a first C-section affects the formation of a scar defect (niche) in the uterus. Researchers will compare women who get a bladder flap to those who don't, using an ultrasound 6-8 weeks after delivery. The goal is to see if s…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC